3.9 Article

The CR1 C5507G polymorphism is not involved in susceptibility to idiopathic pulmonary fibrosis in two European populations

Journal

TISSUE ANTIGENS
Volume 72, Issue 5, Pages 483-486

Publisher

WILEY
DOI: 10.1111/j.1399-0039.2008.01133.x

Keywords

case-control study; complement receptor 1; European population; gene polymorphism; genetics of complex diseases; idiopathic pulmonary fibrosis

Funding

  1. Internal Grant Agency of the Ministry of Health, Czech Republic [IGA NR9037]
  2. Czech government [MSYCR-MSM6198959205]

Ask authors/readers for more resources

Idiopathic pulmonary fibrosis (IPF), a severe lung disease with unknown aetiology, is thought to have an important genetic component. Single nucleotide polymorphism, C5507G, of the complement receptor 1 (CR1) gene, which affects the number of CR1 molecules on erythrocytes, has been associated with susceptibility to IPF in a single European population. To replicate this finding, 53 Czech IPF patients with 203 Czech healthy control subjects and 70 English IPF patients with 149 English controls were investigated. In both populations, there were no significant differences in distribution of CR1 C5507G variants between IPF patients and their appropriate control groups. In conclusion, the association of the CR1 C5507G polymorphism with susceptibility to IPF was not reproducible in Czech and English populations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available